Condition
Malignant Mesothelioma
Estimated Enrollment: 12
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CDR0000269674|RPCI-RP-9812
Study First Received: February 5, 2003
Last Updated: February 25, 2011
Estimated Primary Completion Date: June 2006
Primary Outcome Measures:
Feasibility|Comparison of results from this regimen to historical controls|Toxic effects
Sponsors and Collaborators:
Roswell Park Cancer Institute
Website Link: https://ClinicalTrials.gov/show/NCT00054002
